These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35529445)

  • 1. Study on the Characteristics of Small-Molecule Kinase Inhibitors-Related Drug-Induced Liver Injury.
    Dong H; You J; Zhao Y; Zheng D; Zhong Y; Li G; Weng Z; Luo H; Jiang S
    Front Pharmacol; 2022; 13():838397. PubMed ID: 35529445
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatotoxicity reports in the FDA adverse event reporting system database: A comparison of drugs that cause injury
    Rana P; Aleo MD; Wen X; Kogut S
    Acta Pharm Sin B; 2021 Dec; 11(12):3857-3868. PubMed ID: 35024312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 31 FDA approved small-molecule kinase inhibitors on isolated rat liver mitochondria.
    Zhang J; Salminen A; Yang X; Luo Y; Wu Q; White M; Greenhaw J; Ren L; Bryant M; Salminen W; Papoian T; Mattes W; Shi Q
    Arch Toxicol; 2017 Aug; 91(8):2921-2938. PubMed ID: 28032146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury.
    Chen M; Borlak J; Tong W
    Hepatology; 2013 Jul; 58(1):388-96. PubMed ID: 23258593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in silico identification of human bile salt export pump (ABCB11) inhibitors associated with cholestatic drug-induced liver injury.
    Xi L; Yao J; Wei Y; Wu X; Yao X; Liu H; Li S
    Mol Biosyst; 2017 Jan; 13(2):417-424. PubMed ID: 28092392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The integrated stress response-related expression of CHOP due to mitochondrial toxicity is a warning sign for DILI liability.
    Vlasveld M; Callegaro G; Fisher C; Eakins J; Walker P; Lok S; van Oost S; de Jong B; Pellegrino-Coppola D; Burger G; Wink S; van de Water B
    Liver Int; 2024 Mar; 44(3):760-775. PubMed ID: 38217387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
    Aleo MD; Luo Y; Swiss R; Bonin PD; Potter DM; Will Y
    Hepatology; 2014 Sep; 60(3):1015-22. PubMed ID: 24799086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moving beyond Binary Predictions of Human Drug-Induced Liver Injury (DILI) toward Contrasting Relative Risk Potential.
    Aleo MD; Shah F; Allen S; Barton HA; Costales C; Lazzaro S; Leung L; Nilson A; Obach RS; Rodrigues AD; Will Y
    Chem Res Toxicol; 2020 Jan; 33(1):223-238. PubMed ID: 31532188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of 34 FDA approved small-molecule kinase inhibitors in primary rat and human hepatocytes.
    Zhang J; Ren L; Yang X; White M; Greenhaw J; Harris T; Wu Q; Bryant M; Papoian T; Mattes W; Shi Q
    Toxicol Lett; 2018 Jul; 291():138-148. PubMed ID: 29655783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Model to predict severity of drug-induced liver injury in humans.
    Chen M; Borlak J; Tong W
    Hepatology; 2016 Sep; 64(3):931-40. PubMed ID: 27302180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Drug-Induced Liver Injury Prediction: Criteria Optimization of Efflux Transporter IC50 and Physicochemical Properties.
    Yucha RW; He K; Shi Q; Cai L; Nakashita Y; Xia CQ; Liao M
    Toxicol Sci; 2017 Jun; 157(2):487-499. PubMed ID: 28369588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced liver injury.
    Leise MD; Poterucha JJ; Talwalkar JA
    Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of the likelihood of drug interactions with kinase inhibitors based on in vitro and computational studies.
    Wang ZX; Sun J; Howell CE; Zhou QY; He ZX; Yang T; Chew H; Duan W; Zhou ZW; Kanwar JR; Zhou SF
    Fundam Clin Pharmacol; 2014 Oct; 28(5):551-82. PubMed ID: 24612223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A gene expression profile-based approach to screen the occurrence and predisposed host characteristics of drug-induced liver injury: a case study of
    Zhang ML; Li WX; Wang XY; Zhang H; Wu YL; Yang LQ; Chen XF; Zhang SQ; Chen YL; Feng KR; Tang JF
    Front Chem; 2023; 11():1259569. PubMed ID: 37867998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A testing strategy to predict risk for drug-induced liver injury in humans using high-content screen assays and the 'rule-of-two' model.
    Chen M; Tung CW; Shi Q; Guo L; Shi L; Fang H; Borlak J; Tong W
    Arch Toxicol; 2014 Jul; 88(7):1439-49. PubMed ID: 24958025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational Prediction of the Site(s) of Metabolism and Binding Modes of Protein Kinase Inhibitors Metabolized by CYP3A4.
    Nair PC; McKinnon RA; Miners JO
    Drug Metab Dispos; 2019 Jun; 47(6):616-631. PubMed ID: 30902802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of binary classification models for assessment of drug-induced liver injury in humans using a large set of FDA-approved drugs.
    Zhang H; Zhang HR; Hu ML; Qi HZ
    J Pharmacol Toxicol Methods; 2022; 116():107185. PubMed ID: 35623583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Drug-Induced Liver Injury Using Machine Learning on a Diverse Set of Predictors.
    Adeluwa T; McGregor BA; Guo K; Hur J
    Front Pharmacol; 2021; 12():648805. PubMed ID: 34483896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic imaging of adaptive stress response pathway activation for prediction of drug induced liver injury.
    Wink S; Hiemstra SW; Huppelschoten S; Klip JE; van de Water B
    Arch Toxicol; 2018 May; 92(5):1797-1814. PubMed ID: 29502165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, characteristics and risk factors for drug-induced liver injury in hospitalized patients: A matched case-control study.
    Kong X; Guo D; Liu S; Zhu Y; Yu C
    Br J Clin Pharmacol; 2021 Nov; 87(11):4304-4312. PubMed ID: 33948989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.